Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Monopar Therapeutics Inc. (MNPR)
USD103.33
-3.27 (-3.07%)
US NASDAQ Healthcare Biotechnology
Address
1000 Skokie Boulevard 60091
Wilmette, IL, US
Wilmette, IL, US
CEO
Chandler D. Robinson
Website
monopartx.com
IPO
2019-12-19
CIK 1645469 ISIN US61023L2079
Description
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase 1 imaging and dosimetry clinical trial, a radiopharmaceutical imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a Phase1a stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; Excel Diagnostics and Nuclear Oncology Center, for the investigational imaging agent MNPR-101-Zr and investigational therapeutic agent MNPR-101-Lu; license agreement with Alexion to develop and commercialize ALXN1840, a drug candidate for Wilson disease. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD103.33
-3.27 (-3.07%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
171.5K
Beta
1.54
Float Shares
4.40M
Free Float %
65.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.73% | -0.93% | +5.30% | +9.97% | -21.81% | -6.60% | +64.35% | +1,318.37% | +138.71% | -53.97% | -53.97% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (13 ratings, all time)
Buy
Price Targets & DCF
Current price
103.33
Low
115.00
+11.3%
Consensus
115.00
+11.3%
Median
115.00
+11.3%
High
115.00
+11.3%
DCF (Unlevered)
8,322.24
+7,954.0%
DCF (Levered)
8,322.58
+7,954.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 10 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 12 |
103.83
+0.5%
|
| All Time | 14 |
93.21
-9.8%
|
Quality scores
Altman Z-Score
0.20
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-36.0% Q1'26: -21.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%0.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%-35.5% ★ Q1'26: +22.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-9.27× Q1'26: -0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 9 EPS Ana. |
Dec 2027 7 Rev. Ana. 7 EPS Ana. |
Dec 2028 7 Rev. Ana. 6 EPS Ana. |
Dec 2029 3 Rev. Ana. 4 EPS Ana. |
Dec 2030 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
400.0K
128.7K – 568.9K
|
17.31M
3.35M – 26.00M
+4,227.2% YoY
|
83.08M
26.73M – 118.17M
+380.0% YoY
|
169.86M
54.65M – 241.59M
+104.4% YoY
|
270.22M
86.95M – 384.33M
+59.1% YoY
|
| EBITDA |
-16.16M
|
-16.70M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-16.16M
|
-16.70M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-15.59M
est: -15.80M (+1.4%)
|
-13.72M
est: -13.72M (+0.0%)
|
-31.71M
-48.20M – -17.68M
-131.2% YoY
|
-36.55M
-54.53M – -11.13M
-15.3% YoY
|
-11.47M
-28.98M – 19.54M
+68.6% YoY
|
6.94M
821.1K – 10.75M
+160.5% YoY
|
38.02M
4.50M – 58.89M
+447.7% YoY
|
| SGA |
3.16M
|
6.80B
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.36
est: -1.38 (+1.2%)
|
-1.85
est: -1.68 (-10.1%)
|
-3.69
-6.50 – -2.39
-119.4% YoY
|
-3.58
-7.36 – -1.50
+3.0% YoY
|
-0.97
-3.91 – 2.64
+72.8% YoY
|
0.94
0.11 – 1.45
+196.5% YoY
|
5.13
0.61 – 7.95
+447.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-15 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
10
Total invested
8.96M
Insider transactions (90d)
0
Beneficial owners (>5%)
20
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BROWN | 4.66M | 44.00% | 257.1K | 4.40M | 257.1K | — | IN | USA | 2019-12-23 | ↗ |
| 2 | ROBINSON | 4.61M | 43.00% | 204.9K | 4.40M | 204.9K | — | IN | USA | 2019-12-23 | ↗ |
| 3 | MAZAR | 4.60M | 43.00% | 201.4K | 4.40M | 201.4K | — | IN | USA | 2019-12-23 | ↗ |
| 4 | O’HALLORAN | 4.42M | 42.00% | 14.0K | 4.40M | 14.0K | — | IN | USA | 2019-12-23 | ↗ |
| 5 | Tactic Pharma LLC | 4.40M | 42.00% | 4.40M | — | 4.40M | — | OO | DELAWARE | 2019-12-23 | ↗ |
| 6 | HENDRICKS | 3.52M | 33.00% | 468.8K | 3.06M | 468.8K | — | IN | USA | 2019-12-23 | ↗ |
| 7 | LEO | 3.21M | 30.00% | 156.6K | 3.06M | 156.6K | — | IN | USA | 2019-12-23 | ↗ |
| 8 | KLAUSNER | 3.09M | 29.00% | 38.8K | 3.06M | 38.8K | — | IN | USA | 2019-12-23 | ↗ |
| 9 | GEM PHARMACEUTICALS LLC | 3.06M | 29.00% | 3.06M | — | 3.06M | — | OO | ALABAMA | 2019-12-23 | ↗ |
| 10 | INVESTMENTS LLC | 3.06M | 29.00% | — | 3.06M | — | — | OO | Alabama | 2019-12-23 | ↗ |
| 11 | Jeffrey Klunzinger | 692.8K | 5.24% | 692.8K | — | 692.8K | — | IN | United States | 2023-06-02 | ↗ |
| 12 | EIN #00-0000000 | 562.5K | 10.90% | — | 562.5K | — | 562.5K | IA, HC | Jersey, Channel Islands | 2024-11-06 | ↗ |
| 13 | Peter Kolchinsky | 511.2K | 9.70% | — | 511.2K | — | — | HC, IN | Delaware | 2024-10-31 | ↗ |
| 14 | RA Capital Healthcare Fund, L.P. | 511.2K | 9.70% | — | 511.2K | — | — | PN | Delaware | 2024-10-31 | ↗ |
| 15 | RA Capital Management, L.P. | 511.2K | 9.70% | — | 511.2K | — | — | IA, PN | Delaware | 2024-10-31 | ↗ |
| 16 | Rajeev Shah | 511.2K | 9.70% | — | 511.2K | — | — | HC, IN | Delaware | 2024-10-31 | ↗ |
| 17 | 00-0000000 | 504.6K | 9.80% | — | 504.6K | — | 504.6K | IV | Massachusetts | 2024-11-06 | ↗ |
| 18 | Alexion Pharmaceuticals, Inc. | 387.3K | 9.90% | 387.3K | — | 387.3K | — | CO | United Kingdom | 2024-10-28 | ↗ |
| 19 | AstraZeneca PLC | 387.3K | 9.90% | 387.3K | — | 387.3K | — | CO | United Kingdom | 2024-10-28 | ↗ |
| 20 | Tang Capital Management, LLC | 200.0K | 5.10% | — | 200.0K | — | 200.0K | OO | DELAWARE | 2024-10-24 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
10
-62 vs prev Q
New positions
1
Closed positions
63
Increased
5
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | JANUS HENDERSON GROUP PLC | 1.32M +30.0K (+2.3%) | 85.91M -19.4M (-18.4%) | 18.49% +0.097 pp | 0.04% -0.010 pp | USD29.55 +121.0% | 5 qtrs — |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 667.2K +156.0K (+30.5%) | 43.57M +1.8M (+4.4%) | 9.37% +2.061 pp | 0.45% -0.068 pp | USD32.12 +103.3% | 5 qtrs — |
| 3 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 639.5K -19.7K (-3.0%) | 41.76M -12.1M (-22.4%) | 8.98% -0.443 pp | 0.06% -0.022 pp | USD27.43 +138.1% | 5 qtrs — |
| 4 | SATURN V CAPITAL MANAGEMENT LLC | 325.7K +170.3K (+109.6%) | 21.27M +8.6M (+67.6%) | 4.57% +2.352 pp | 3.90% +1.120 pp | USD73.11 -10.7% | 2 qtrs — |
| 5 | VANGUARD GROUP INC | 293.8K +85.6K (+41.1%) | 19.19M +2.2M (+12.8%) | 4.12% +1.149 pp | 0.00% +0.000 pp | USD60.80 +7.4% | 5 qtrs — |
| 6 | BLACKROCK, INC. | 254.9K +51.1K (+25.1%) | 16.64M +1.8K (+0.0%) | 3.58% +0.666 pp | 0.00% +0.000 pp | USD41.28 +58.2% | 5 qtrs — |
| 7 | ADAR1 CAPITAL MANAGEMENT, LLC | 233.9K +103.9K (+79.9%) | 15.27M +4.7M (+43.9%) | 3.28% +1.426 pp | 1.12% +0.125 pp | USD48.65 +34.2% | 5 qtrs — |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 226.1K -5.4K (-2.3%) | 14.76M -4.1M (-21.9%) | 3.17% -0.134 pp | 0.00% -0.001 pp | USD81.67 -20.0% | 2 qtrs — |
| 9 | SIREN, L.L.C. | 212.3K +212.3K (+100.0%) | 13.86M +13.9M (+100.0%) | 2.98% +2.980 pp | 0.41% +0.414 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 10 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 170.6K +10.8K (+6.8%) | 11.14M -1.9M (-14.6%) | 2.39% +0.111 pp | 0.14% -0.057 pp | USD80.63 -19.0% | 2 qtrs — |
| 11 | TCG CROSSOVER MANAGEMENT, LLC | 141.9K -11.1K (-7.2%) | 9.27M -3.2M (-25.8%) | 1.99% -0.194 pp | 0.31% -0.308 pp | USD81.67 -20.0% | 2 qtrs — |
| 12 | POLAR CAPITAL HOLDINGS PLC | 105.8K +105.8K (+100.0%) | 6.91M +6.9M (+100.0%) | 1.48% +1.485 pp | 0.03% +0.027 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 99.0K +14.0K (+16.5%) | 6.47M -474.0K (-6.8%) | 1.39% +0.176 pp | 0.00% +0.000 pp | USD33.41 +95.5% | 6 qtrs — |
| 14 | DEEP TRACK CAPITAL, LP | 95.4K +95.4K (+100.0%) | 6.23M +6.2M (+100.0%) | 1.34% +1.339 pp | 0.11% +0.111 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 15 | VIVO CAPITAL, LLC | 90.5K +— (+0.0%) | 5.91M -1.5M (-20.0%) | 1.27% -0.023 pp | 0.38% -0.213 pp | USD81.67 -20.0% | 2 qtrs — |
| 16 | STATE STREET CORP | 84.0K +11.8K (+16.3%) | 5.48M -415.2K (-7.0%) | 1.18% +0.147 pp | 0.00% +0.000 pp | USD56.65 +15.3% | 4 qtrs — |
| 17 | MILLENNIUM MANAGEMENT LLC | 76.7K +69.3K (+945.5%) | 5.01M +4.4M (+735.9%) | 1.08% +0.972 pp | 0.00% +0.002 pp | USD62.54 +4.4% | 4 qtrs — |
| 18 | BANK OF NEW YORK MELLON CORP | 64.9K +47.7K (+277.7%) | 4.24M +2.8M (+202.0%) | 0.91% +0.665 pp | 0.00% +0.001 pp | USD63.30 +3.2% | 3 qtrs — |
| 19 | ALYESKA INVESTMENT GROUP, L.P. | 40.0K +27.8K (+227.5%) | 2.61M +1.6M (+161.8%) | 0.56% +0.387 pp | 0.01% +0.004 pp | USD70.30 -7.1% | 2 qtrs — |
| 20 | DRIEHAUS CAPITAL MANAGEMENT LLC | 33.7K -30.9K (-47.8%) | 2.20M -3.1M (-58.3%) | 0.47% -0.450 pp | 0.02% -0.023 pp | USD81.67 -20.0% | 2 qtrs — |
| 21 | NEUBERGER BERMAN GROUP LLC | 32.5K +32.5K (+100.0%) | 2.13M +2.1M (+100.0%) | 0.46% +0.457 pp | 0.00% +0.002 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 22 | BALYASNY ASSET MANAGEMENT L.P. | 31.9K +31.9K (+100.0%) | 2.08M +2.1M (+100.0%) | 0.45% +0.448 pp | 0.00% +0.003 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 23 | NORTHERN TRUST CORP | 30.5K +3.6K (+13.5%) | 1.99M -202.4K (-9.2%) | 0.43% +0.044 pp | 0.00% +0.000 pp | USD39.46 +65.5% | 4 qtrs — |
| 24 | MORGAN STANLEY | 27.0K +11.3K (+71.6%) | 1.76M +477.8K (+37.2%) | 0.38% +0.154 pp | 0.00% +0.000 pp | USD60.61 +7.7% | 5 qtrs — |
| 25 | PRICE T ROWE ASSOCIATES INC /MD/ | 22.7K +22.7K (+100.0%) | 1.49M +1.5M (+100.0%) | 0.32% +0.319 pp | 0.00% +0.000 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 26 | BARCLAYS PLC | 20.2K +5.2K (+34.2%) | 1.32M +90.3K (+7.3%) | 0.28% +0.069 pp | 0.00% +0.000 pp | USD60.98 +7.1% | 4 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 14.3K +2.5K (+21.1%) | 932.8K -30.7K (-3.2%) | 0.20% +0.032 pp | 0.00% +0.000 pp | USD40.92 +59.6% | 3 qtrs — |
| 28 | CITIGROUP INC | 13.8K +13.7K (+9,065.6%) | 903.8K +891.4K (+7,228.5%) | 0.19% +0.192 pp | 0.00% +0.000 pp | USD64.98 +0.5% | 4 qtrs — |
| 29 | RENAISSANCE TECHNOLOGIES LLC | 11.4K +11.4K (+100.0%) | 746.4K +746.4K (+100.0%) | 0.16% +0.161 pp | 0.00% +0.001 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 30 | EAM INVESTORS, LLC | 11.4K -3.3K (-22.3%) | 742.7K -452.1K (-37.8%) | 0.16% -0.049 pp | 0.08% -0.054 pp | USD81.67 -20.0% | 2 qtrs — |
| 31 | SQUAREPOINT OPS LLC | 10.5K +10.5K (+100.0%) | 687.0K +687.0K (+100.0%) | 0.15% +0.148 pp | 0.00% +0.001 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 32 | GOLDMAN SACHS GROUP INC | 10.4K +3.8K (+58.8%) | 676.6K +143.7K (+27.0%) | 0.15% +0.052 pp | 0.00% +0.000 pp | USD75.61 -13.6% | 4 qtrs — |
| 33 | VIRTU FINANCIAL LLC | 10.0K +10.0K (+100.0%) | 654.0K +654.0K (+100.0%) | 0.14% +0.141 pp | 0.03% +0.025 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 34 | SEI INVESTMENTS CO | 6.9K +6.9K (+100.0%) | 452.3K +452.3K (+100.0%) | 0.10% +0.097 pp | 0.00% +0.000 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 35 | BANK OF AMERICA CORP /DE/ | 6.4K +4.2K (+199.6%) | 415.5K +242.0K (+139.5%) | 0.09% +0.059 pp | 0.00% +0.000 pp | USD55.68 +17.3% | 6 qtrs — |
| 36 | MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 6.1K +6.1K (+100.0%) | 398.3K +398.3K (+100.0%) | 0.09% +0.086 pp | 0.06% +0.065 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 37 | STATE OF WISCONSIN INVESTMENT BOARD | 5.8K +5.8K (+100.0%) | 375.9K +375.9K (+100.0%) | 0.08% +0.081 pp | 0.00% +0.001 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 38 | GERBER, LLC | 5.6K +— (+0.0%) | 365.7K -91.7K (-20.0%) | 0.08% -0.001 pp | 0.20% -0.083 pp | USD36.41 +79.3% | 4 qtrs — |
| 39 | NUVEEN, LLC | 5.6K +1.3K (+31.5%) | 362.5K +17.8K (+5.1%) | 0.08% +0.018 pp | 0.00% +0.000 pp | USD77.75 -16.0% | 2 qtrs — |
| 40 | WELLS FARGO & COMPANY/MN | 5.1K +2.8K (+120.8%) | 334.7K +145.1K (+76.6%) | 0.07% +0.039 pp | 0.00% +0.000 pp | USD50.69 +28.8% | 6 qtrs — |
| 41 | CITADEL ADVISORS LLC | 5.1K +5.1K (+100.0%) | 331.3K +331.3K (+100.0%) | 0.07% +0.071 pp | 0.00% +0.000 pp | USD65.30 +0.0% | 3 qtrs — |
| 42 | RHUMBLINE ADVISERS | 5.0K -298.0 (-5.6%) | 325.8K -106.0K (-24.6%) | 0.07% -0.006 pp | 0.00% 0.000 pp | USD35.78 +82.5% | 3 qtrs — |
| 43 | TWO SIGMA INVESTMENTS, LP | 5.0K +5.0K (+100.0%) | 325.8K +325.8K (+100.0%) | 0.07% +0.070 pp | 0.00% +0.001 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 44 | ENGINEERS GATE MANAGER LP | 4.3K +4.3K (+100.0%) | 283.3K +283.3K (+100.0%) | 0.06% +0.061 pp | 0.00% +0.003 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 45 | UBS GROUP AG | 4.3K -3.7K (-46.7%) | 277.5K -373.6K (-57.4%) | 0.06% -0.054 pp | 0.00% 0.000 pp | USD31.42 +107.8% | 6 qtrs — |
| 46 | TREXQUANT INVESTMENT LP | 3.8K +3.8K (+100.0%) | 246.7K +246.7K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.002 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 47 | VIRTUS INVESTMENT ADVISERS, INC. | 3.6K +3.6K (+100.0%) | 232.8K +232.8K (+100.0%) | 0.05% +0.050 pp | 0.06% +0.063 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 48 | DEUTSCHE BANK AG\ | 3.4K -639.0 (-15.9%) | 220.3K -107.4K (-32.8%) | 0.05% -0.010 pp | 0.00% +0.000 pp | USD42.95 +52.0% | 3 qtrs — |
| 49 | INVESCO LTD. | 3.4K +3.4K (+100.0%) | 219.1K +219.1K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 50 | TD ASSET MANAGEMENT INC | 3.1K +3.1K (+100.0%) | 201.4K +201.4K (+100.0%) | 0.04% +0.043 pp | 0.00% +0.000 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 51 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 2.9K +2.9K (+100.0%) | 188.0K +188.0K (+100.0%) | 0.04% +0.040 pp | 0.05% +0.046 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 52 | METLIFE INVESTMENT MANAGEMENT, LLC | 2.5K +— (+0.0%) | 165.7K -41.5K (-20.0%) | 0.04% -0.001 pp | 0.00% 0.000 pp | USD35.78 +82.5% | 3 qtrs — |
| 53 | JPMORGAN CHASE & CO | 2.1K +618.0 (+41.4%) | 137.7K +15.9K (+13.1%) | 0.03% +0.008 pp | 0.00% +0.000 pp | USD43.92 +48.7% | 5 qtrs — |
| 54 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 2.1K +461.0 (+28.3%) | 136.5K +3.4K (+2.6%) | 0.03% +0.006 pp | 0.00% +0.000 pp | USD42.29 +54.4% | 3 qtrs — |
| 55 | QUEST PARTNERS LLC | 2.0K +48.0 (+2.5%) | 129.5K -28.5K (-18.1%) | 0.03% +0.000 pp | 0.01% -0.003 pp | USD40.37 +61.8% | 4 qtrs — |
| 56 | CANADA PENSION PLAN INVESTMENT BOARD | 1.4K +1.4K (+100.0%) | 91.4K +91.4K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 57 | NEW YORK STATE COMMON RETIREMENT FUND | 1.2K +— (+0.0%) | 78.4K -19.6K (-20.0%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD35.78 +82.5% | 3 qtrs — |
| 58 | BNP PARIBAS ARBITRAGE, SNC | 1.0K +319.0 (+45.8%) | 66.3K +9.4K (+16.6%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD60.83 +7.3% | 3 qtrs — |
| 59 | MEEDER ASSET MANAGEMENT INC | 994.00 +994.0 (+100.0%) | 64.9K +64.9K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.004 pp | USD65.30 +0.0% | 1 qtrs NEW |
| 60 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 964.00 +— (+0.0%) | 62.9K -15.8K (-20.0%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD35.78 +82.5% | 3 qtrs — |
| 61 | NEWEDGE ADVISORS, LLC | 600.00 +— (+0.0%) | 39.2K -9.8K (-20.0%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD6.74 +868.8% | 6 qtrs — |
| 62 | LEGAL & GENERAL GROUP PLC | 479.00 +102.0 (+27.1%) | 31.3K +488.0 (+1.6%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD42.06 +55.3% | 3 qtrs — |
| 63 | FMR LLC | 358.00 +8.0 (+2.3%) | 23.4K -5.2K (-18.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD77.33 -15.6% | 3 qtrs — |
| 64 | TOWER RESEARCH CAPITAL LLC (TRC) | 347.00 -205.0 (-37.1%) | 22.7K -22.4K (-49.7%) | 0.00% -0.003 pp | 0.00% -0.001 pp | USD81.67 -20.0% | 5 qtrs — |
| 65 | RUSSELL INVESTMENTS GROUP, LTD. | 341.00 +4.0 (+1.2%) | 22.3K -5.3K (-19.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.48 -19.9% | 2 qtrs — |
| 66 | ROYAL BANK OF CANADA | 326.00 +251.0 (+334.7%) | 22.0K +16.0K (+266.7%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD66.42 -1.7% | 4 qtrs — |
| 67 | AMERITAS INVESTMENT PARTNERS, INC. | 300.00 +— (+0.0%) | 19.6K -4.9K (-20.0%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD35.78 +82.5% | 3 qtrs — |
| 68 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 281.00 +26.0 (+10.2%) | 18.3K -2.5K (-11.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD38.67 +68.9% | 3 qtrs — |
| 69 | AMALGAMATED BANK | 144.00 +5.0 (+3.6%) | 9.0K -2.0K (-18.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD36.80 +77.4% | 3 qtrs — |
| 70 | ALLWORTH FINANCIAL LP | 100.00 +— (+0.0%) | 6.5K -1.6K (-20.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD36.40 +79.4% | 4 qtrs — |
| 71 | STERLING CAPITAL MANAGEMENT LLC | 29.00 +20.0 (+222.2%) | 1.9K +1.2K (+157.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD56.10 +16.4% | 3 qtrs — |
| 72 | GAMMA INVESTING LLC | 14.00 +3.0 (+27.3%) | 914.00 +16.0 (+1.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD78.07 -16.4% | 2 qtrs — |
| 73 | AFFINITY ASSET ADVISORS, LLC | — -79.5K (-100.0%) | — -6.5M (-100.0%) | 0.00% -1.136 pp | 0.00% -0.566 pp | USD— | 4 qtrs SOLD |
| 74 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | — -3.5K (-100.0%) | — -286.5K (-100.0%) | 0.00% -0.050 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 75 | SRS CAPITAL ADVISORS, INC. | — -14.0 (-100.0%) | — -1.1K (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 76 | ALLY BRIDGE GROUP (NY) LLC | — -64.5K (-100.0%) | — -5.3M (-100.0%) | 0.00% -0.921 pp | 0.00% -3.206 pp | USD— | 3 qtrs SOLD |
| 77 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | — -4.3K (-100.0%) | — -353.5K (-100.0%) | 0.00% -0.062 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
4
Sells
4
Shares acquired
61.0K
Shares disposed
13.8K
Cash buys
—
Cash sales
—
Net activity
+47,185
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Robinson Chandler | Director / Officer | M-Exempt | D | Restricted Stock Unit | 6,732 | 0.00 | — | 106,276 | D | ↗ |
| 2026-03-31 | Cittadine Andrew | Officer | M-Exempt | A | Common Stock | 3,514 | 0.00 | — | 54,240 | D | ↗ |
| 2026-03-02 | Rodriguez Susan | Officer | A-Award | A | Stock Options | 48,728 | 53.47 | 2.61M | 48,728 | D | ↗ |
| 2026-01-01 | RIOUX PATRICE | Officer | A-Award | A | Stock Option | 2,000 | 65.30 | 130.6K | 2,000 | D | ↗ |
| 2025-12-31 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 2,558 | 65.30 | 167.0K | 85,718 | D | ↗ |
| 2025-12-31 | Cittadine Andrew | Officer | M-Exempt | D | Restricted Stock Unit | 4,326 | 0.00 | — | 48,267 | D | ↗ |
| 2025-12-26 | Vu Quan Anh | Officer | P-Purchase | A | Common Stock | 1,500 | 69.95 | 104.9K | 1,500 | D | ↗ |
| 2025-12-18 | KLAUSNER ARTHUR J | Director | S-Sale | D | Common Stock | 4,660 | 67.06 | 312.5K | 9,223 | D | ↗ |
| 2025-12-16 | KLAUSNER ARTHUR J | Director | J-Other | A | Common Stock | 7,710 | 0.00 | — | 13,883 | D | ↗ |
| 2025-12-16 | Hendricks Diane | 10% Owner | J-Other | D | Common Stock | 43,499 | 0.00 | — | 567,580 | I | ↗ |
| 2025-12-02 | Vu Quan Anh | Officer | A-Award | A | Stock Options | 7,135 | 75.94 | 541.8K | 7,135 | D | ↗ |
| 2025-12-02 | Tsuchimoto Kim R | Director | A-Award | A | Stock Options | 2,924 | 75.94 | 222.0K | 2,924 | D | ↗ |
| 2025-12-02 | Talukdar Lavina | Director | A-Award | A | Stock Options | 2,924 | 75.94 | 222.0K | 2,924 | D | ↗ |
| 2025-12-02 | STARR CHRISTOPHER M | Director | A-Award | A | Stock Options | 2,924 | 75.94 | 222.0K | 2,924 | D | ↗ |
| 2025-12-02 | Robinson Chandler | Director / Officer | A-Award | A | Stock Options | 16,753 | 75.94 | 1.27M | 16,753 | D | ↗ |
| 2025-12-02 | KLAUSNER ARTHUR J | Director | A-Award | A | Stock Options | 2,924 | 75.94 | 222.0K | 2,924 | D | ↗ |
| 2025-12-02 | Cittadine Andrew | Officer | A-Award | A | Stock Options | 8,969 | 75.94 | 681.1K | 8,969 | D | ↗ |
| 2025-12-02 | Anderson Raymond | Director | A-Award | A | Stock Options | 2,924 | 75.94 | 222.0K | 2,924 | D | ↗ |
| 2025-09-30 | Robinson Chandler | Director / Officer | M-Exempt | A | Common Stock | 8,726 | 0.00 | — | 82,198 | D | ↗ |
| 2025-09-30 | Cittadine Andrew | Officer | M-Exempt | A | Common Stock | 4,327 | 0.00 | — | 50,185 | D | ↗ |
| 2025-09-24 | Tactic Pharma LLC | 10% Owner | S-Sale | D | Common Stock | 550,229 | 63.61 | 35.00M | 272,026 | D | ↗ |
| 2025-07-14 | Tsuchimoto Kim R | Director | X-InTheMoney | D | Stock Options | 4,704 | 0.01 | 23.52 | 0 | D | ↗ |
| 2025-07-14 | STARR CHRISTOPHER M | Director | S-Sale | D | Common Stock | 16,800 | 40.00 | 672.0K | 5,173 | D | ↗ |
| 2025-07-14 | Robinson Chandler | Director / Officer | X-InTheMoney | D | Stock Options | 16,800 | 0.01 | 84.00 | 0 | D | ↗ |
| 2025-06-30 | Robinson Chandler | Director / Officer | M-Exempt | D | Restricted Stock Units | 13,344 | 0.00 | — | 81,325 | D | ↗ |
| 2025-06-30 | Cittadine Andrew | Officer | M-Exempt | A | Common Stock | 6,863 | 0.00 | — | 48,848 | D | ↗ |
| 2025-04-02 | Tactic Pharma LLC | 10% Owner | S-Sale | D | Common Stock | 33,334 | 35.00 | 1.17M | 822,255 | D | ↗ |
| 2025-03-31 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 1,204 | 36.41 | 43.8K | 65,993 | D | ↗ |
| 2025-03-31 | Cittadine Andrew | Officer | F-InKind | D | Common Stock | 744 | 36.41 | 27.1K | 41,985 | D | ↗ |
| 2025-03-04 | Tsuchimoto Kim R | Director | A-Award | A | Stock Options | 11,365 | 31.70 | 360.3K | 11,365 | D | ↗ |
| 2025-03-04 | Talukdar Lavina | Director | A-Award | A | Stock Options | 5,683 | 31.70 | 180.2K | 5,683 | D | ↗ |
| 2025-03-04 | STARR CHRISTOPHER M | Director | A-Award | A | Stock Options | 11,365 | 31.70 | 360.3K | 11,365 | D | ↗ |
| 2025-03-04 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 1,759 | 31.70 | 55.8K | 63,091 | D | ↗ |
| 2025-03-04 | KLAUSNER ARTHUR J | Director | A-Award | A | Stock Options | 11,365 | 31.70 | 360.3K | 11,365 | D | ↗ |
| 2025-03-04 | Cittadine Andrew | Officer | A-Award | A | Stock Options | 43,445 | 31.70 | 1.38M | 43,445 | D | ↗ |
| 2025-03-04 | Anderson Raymond | Director | A-Award | A | Stock Options | 11,365 | 31.70 | 360.3K | 11,365 | D | ↗ |
| 2025-03-03 | Vu Quan Anh | Officer | A-Award | A | Stock Options | 25,000 | 30.93 | 773.3K | 25,000 | D | ↗ |
| 2025-02-21 | Talukdar Lavina | Director | — | — | Common Stock | 0 | 0.00 | — | 14,001 | D | ↗ |
| 2025-01-28 | Robinson Chandler | Director / Officer | J-Other | A | Common Stock | 62,815 | 0.00 | — | 62,815 | I | ↗ |
| 2025-01-01 | RIOUX PATRICE | Officer | A-Award | A | Stock Options | 2,000 | 22.00 | 44.0K | 2,000 | D | ↗ |
| 2024-12-31 | Robinson Chandler | Director / Officer | M-Exempt | A | Common Stock | 4,895 | 0.00 | — | 61,057 | D | ↗ |
| 2024-12-31 | Cittadine Andrew | Officer | M-Exempt | A | Common Stock | 1,790 | 0.00 | — | 41,659 | D | ↗ |
| 2024-12-09 | TacticGem LLC | 10% Owner | J-Other | D | Common Stock | 1,433,334 | 0.00 | — | 0 | D | ↗ |
| 2024-10-28 | Radhakrishnan Karthik | Officer | P-Purchase | A | Common Stock | 1,550 | 16.25 | 25.2K | 1,550 | D | ↗ |
| 2024-09-30 | Robinson Chandler | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,895 | 0.00 | — | 29,774 | D | ↗ |
| 2024-09-30 | Cittadine Andrew | Officer | M-Exempt | D | Restricted Stock Units | 1,791 | 0.00 | — | 12,864 | D | ↗ |
| 2024-07-01 | Radhakrishnan Karthik | Officer | A-Award | A | Stock Options | 125,000 | 0.74 | 92.7K | 125,000 | — | ↗ |
| 2024-06-30 | Tsuchimoto Kim R | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,957 | 0.00 | — | 74,412 | — | ↗ |
| 2024-06-30 | Robinson Chandler | Director / Officer | M-Exempt | D | Restricted Stock Units | 24,476 | 0.00 | — | 173,335 | — | ↗ |
| 2024-06-30 | Cittadine Andrew | Officer | M-Exempt | A | Common Stock | 8,952 | 0.00 | — | 195,084 | — | ↗ |
| 2024-06-20 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 20,508 | 0.74 | 15.3K | 186,132 | — | ↗ |
| 2024-06-18 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.86 | 10.3K | 165,624 | — | ↗ |
| 2024-06-17 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.90 | 10.8K | 153,624 | — | ↗ |
| 2024-06-14 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.93 | 11.2K | 141,624 | — | ↗ |
| 2024-06-13 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.91 | 10.9K | 129,624 | — | ↗ |
| 2024-06-04 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.78 | 9.4K | 117,624 | — | ↗ |
| 2024-06-03 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.76 | 9.1K | 105,624 | — | ↗ |
| 2024-05-31 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.64 | 7.7K | 93,624 | — | ↗ |
| 2024-05-30 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.64 | 7.7K | 81,624 | — | ↗ |
| 2024-05-29 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 12,000 | 0.64 | 7.6K | 69,624 | — | ↗ |
| 2024-05-28 | Robinson Chandler | Director / Officer | X-InTheMoney | A | Common Stock | 84,000 | 0.00 | 84.00 | 250,131 | — | ↗ |
| 2024-05-22 | Cittadine Andrew | Officer | A-Award | A | Stock Options | 25,000 | 0.61 | 15.4K | 25,000 | — | ↗ |
| 2024-03-31 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 4,082 | 0.68 | 2.8K | 50,470 | — | ↗ |
| 2024-03-31 | Robinson Chandler | Director / Officer | M-Exempt | D | Restricted Stock Units | 24,474 | 0.00 | — | 197,811 | — | ↗ |
| 2024-03-31 | Cittadine Andrew | Officer | F-InKind | D | Common Stock | 3,098 | 0.68 | 2.1K | 57,624 | — | ↗ |
| 2024-01-01 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 505 | 0.34 | 171.80 | 44,596 | — | ↗ |
| 2024-01-01 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 2,327 | 0.34 | 791.65 | 148,829 | — | ↗ |
| 2024-01-01 | RIOUX PATRICE | — | A-Award | A | Stock Options | 10,000 | 0.34 | 3.4K | 10,000 | — | ↗ |
| 2023-12-31 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 4,073 | 0.34 | 1.4K | 43,870 | — | ↗ |
| 2023-12-31 | STARR CHRISTOPHER M | Director | M-Exempt | D | Restricted Stock Units | 2,533 | 0.00 | — | 0 | — | ↗ |
| 2023-12-31 | Robinson Chandler | Director / Officer | M-Exempt | D | Restricted Stock Units | 24,474 | 0.00 | — | 229,009 | — | ↗ |
| 2023-12-31 | KLAUSNER ARTHUR J | Director | M-Exempt | A | Common Stock | 2,533 | 0.00 | — | 30,863 | — | ↗ |
| 2023-12-31 | Cittadine Andrew | Officer | M-Exempt | A | Common Stock | 8,952 | 0.00 | — | 54,868 | — | ↗ |
| 2023-12-31 | Brown Michael J | Director | M-Exempt | A | Common Stock | 2,533 | 0.00 | — | 235,863 | — | ↗ |
| 2023-12-31 | Anderson Raymond | Director | M-Exempt | A | Common Stock | 2,533 | 0.00 | — | 26,863 | — | ↗ |
| 2023-09-30 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 3,444 | 0.62 | 2.1K | 37,986 | — | ↗ |
| 2023-09-30 | STARR CHRISTOPHER M | Director | M-Exempt | A | Common Stock | 2,533 | 0.00 | — | 23,330 | — | ↗ |
| 2023-09-30 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 7,172 | 0.62 | 4.4K | 128,427 | — | ↗ |
| 2023-09-30 | KLAUSNER ARTHUR J | Director | M-Exempt | A | Common Stock | 2,533 | 0.00 | — | 28,330 | — | ↗ |
| 2023-09-30 | Cittadine Andrew | Officer | F-InKind | D | Common Stock | 2,624 | 0.62 | 1.6K | 45,916 | — | ↗ |
| 2023-09-30 | Brown Michael J | Director | M-Exempt | D | Restricted Stock Units | 2,533 | 0.00 | — | 2,533 | — | ↗ |
| 2023-09-30 | Anderson Raymond | Director | M-Exempt | D | Restricted Stock Units | 2,533 | 0.00 | — | 2,533 | — | ↗ |
| 2023-06-30 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 5,104 | 0.86 | 4.4K | 31,474 | — | ↗ |
| 2023-06-30 | STARR CHRISTOPHER M | Director | M-Exempt | A | Common Stock | 2,534 | 0.00 | — | 20,797 | — | ↗ |
| 2023-06-30 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 10,269 | 0.86 | 8.8K | 111,125 | — | ↗ |
| 2023-06-30 | KLAUSNER ARTHUR J | Director | M-Exempt | D | Restricted Stock Units | 2,534 | 0.00 | — | 5,066 | — | ↗ |
| 2023-06-30 | Cittadine Andrew | Officer | M-Exempt | D | Restricted Stock Units | 13,841 | 0.00 | — | 109,080 | — | ↗ |
| 2023-06-30 | Brown Michael J | Director | M-Exempt | D | Restricted Stock Units | 2,534 | 0.00 | — | 5,066 | — | ↗ |
| 2023-06-30 | Anderson Raymond | Director | M-Exempt | D | Restricted Stock Units | 2,534 | 0.00 | — | 5,066 | — | ↗ |
| 2023-03-31 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 1,842 | 1.39 | 2.6K | 21,732 | — | ↗ |
| 2023-03-31 | STARR CHRISTOPHER M | Director | M-Exempt | D | Restricted Stock Units | 2,533 | 0.00 | — | 7,600 | — | ↗ |
| 2023-03-31 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 4,286 | 1.39 | 6.0K | 86,355 | — | ↗ |
| 2023-03-31 | KLAUSNER ARTHUR J | Director | M-Exempt | D | Restricted Stock Units | 2,533 | 0.00 | — | 7,600 | — | ↗ |
| 2023-03-31 | Cittadine Andrew | Officer | M-Exempt | D | Restricted Stock Units | 4,063 | 0.00 | — | 44,687 | — | ↗ |
| 2023-03-31 | Brown Michael J | Director | M-Exempt | D | Restricted Stock Units | 2,533 | 0.00 | — | 7,600 | — | ↗ |
| 2023-03-31 | Anderson Raymond | Director | M-Exempt | D | Restricted Stock Units | 2,533 | 0.00 | — | 7,600 | — | ↗ |
| 2023-02-01 | Tsuchimoto Kim R | Officer | A-Award | A | Stock Options | 102,688 | 3.16 | 324.5K | 102,688 | — | ↗ |
| 2023-02-01 | STARR CHRISTOPHER M | Director | A-Award | A | Restricted Stock Units | 10,133 | 0.00 | — | 10,133 | — | ↗ |
| 2023-02-01 | Robinson Chandler | Director / Officer | A-Award | A | Stock Options | 221,839 | 3.16 | 701.0K | 221,839 | — | ↗ |
| 2023-02-01 | KLAUSNER ARTHUR J | Director | A-Award | A | Stock Options | 13,930 | 3.16 | 44.0K | 13,930 | — | ↗ |
| 2023-02-01 | Cittadine Andrew | Officer | A-Award | A | Stock Options | 102,688 | 3.16 | 324.5K | 102,688 | — | ↗ |
| 2023-02-01 | Brown Michael J | Director | A-Award | A | Restricted Stock Units | 10,133 | 0.00 | — | 10,133 | — | ↗ |
| 2023-02-01 | Anderson Raymond | Director | A-Award | A | Restricted Stock Units | 10,133 | 0.00 | — | 10,133 | — | ↗ |
| 2023-01-01 | Tsuchimoto Kim R | Officer | F-InKind | D | Common Stock | 502 | 2.37 | 1.2K | 18,507 | — | ↗ |
| 2023-01-01 | Robinson Chandler | Officer | M-Exempt | A | Common Stock | 6,723 | 0.00 | — | 79,057 | — | ↗ |
| 2023-01-01 | RIOUX PATRICE | Director | A-Award | A | Stock Options | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-12-31 | Tsuchimoto Kim R | Officer | M-Exempt | A | Common Stock | 5,067 | 0.00 | — | 19,846 | — | ↗ |
| 2022-12-31 | STARR CHRISTOPHER M | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 15,730 | — | ↗ |
| 2022-12-31 | Robinson Chandler | Officer | M-Exempt | A | Common Stock | 13,912 | 0.00 | — | 77,148 | — | ↗ |
| 2022-12-31 | KLAUSNER ARTHUR J | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 20,730 | — | ↗ |
| 2022-12-31 | Cittadine Andrew | Officer | F-InKind | D | Common Stock | 1,406 | 2.37 | 3.3K | 26,894 | — | ↗ |
| 2022-12-31 | Brown Michael J | Director | M-Exempt | D | Restricted Stock Units | 2,859 | 0.00 | — | 0 | — | ↗ |
| 2022-12-31 | Anderson Raymond | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 16,730 | — | ↗ |
| 2022-11-15 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 10,000 | 3.15 | 31.5K | 24,238 | — | ↗ |
| 2022-11-14 | Cittadine Andrew | Officer | P-Purchase | A | Common Stock | 6,053 | 3.00 | 18.2K | 14,238 | — | ↗ |
| 2022-09-30 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 1,753 | 1.52 | 2.7K | 14,779 | — | ↗ |
| 2022-09-30 | STARR CHRISTOPHER M | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 12,871 | — | ↗ |
| 2022-09-30 | Robinson Chandler | Director / Officer | M-Exempt | A | Common Stock | 13,911 | 0.00 | — | 67,313 | — | ↗ |
| 2022-09-30 | KLAUSNER ARTHUR J | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 17,871 | — | ↗ |
| 2022-09-30 | Cittadine Andrew | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,063 | 0.00 | — | 52,812 | — | ↗ |
| 2022-09-30 | Brown Michael J | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 222,871 | — | ↗ |
| 2022-09-30 | Anderson Raymond | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 13,871 | — | ↗ |
| 2022-06-30 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 3,083 | 2.30 | 7.1K | 11,466 | — | ↗ |
| 2022-06-30 | STARR CHRISTOPHER M | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 10,012 | — | ↗ |
| 2022-06-30 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 6,999 | 2.30 | 16.1K | 53,402 | — | ↗ |
| 2022-06-30 | KLAUSNER ARTHUR J | Director | M-Exempt | D | Restricted Stock Units | 2,859 | 0.00 | — | 5,718 | — | ↗ |
| 2022-06-30 | Cittadine Andrew | Director / Officer | F-InKind | D | Common Stock | 2,812 | 2.30 | 6.5K | 5,313 | — | ↗ |
| 2022-06-30 | Brown Michael J | Director | M-Exempt | D | Restricted Stock Units | 2,859 | 0.00 | — | 5,718 | — | ↗ |
| 2022-06-30 | Anderson Raymond | Director | M-Exempt | D | Restricted Stock Units | 2,859 | 0.00 | — | 5,718 | — | ↗ |
| 2022-03-31 | Tsuchimoto Kim R | Director / Officer | F-InKind | D | Common Stock | 500 | 2.55 | 1.3K | 5,636 | — | ↗ |
| 2022-03-31 | STARR CHRISTOPHER M | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 7,153 | — | ↗ |
| 2022-03-31 | Robinson Chandler | Director / Officer | F-InKind | D | Common Stock | 1,155 | 2.55 | 2.9K | 36,519 | — | ↗ |
| 2022-03-31 | Mazar Andrew Paul | Director / Officer | F-InKind | D | Common Stock | 471 | 2.55 | 1.2K | 22,125 | — | ↗ |
| 2022-03-31 | KLAUSNER ARTHUR J | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 12,153 | — | ↗ |
| 2022-03-31 | Brown Michael J | Director | M-Exempt | D | Restricted Stock Units | 2,859 | 0.00 | — | 8,577 | — | ↗ |
| 2022-03-31 | Anderson Raymond | Director | M-Exempt | A | Common Stock | 2,859 | 0.00 | — | 8,153 | — | ↗ |
| 2022-02-02 | Tsuchimoto Kim R | — | A-Award | A | Stock Options | 81,395 | 2.80 | 227.9K | 81,395 | — | ↗ |
| 2022-02-02 | STARR CHRISTOPHER M | — | A-Award | A | Stock Options | 15,128 | 2.80 | 42.4K | 15,128 | — | ↗ |
| 2022-02-02 | Robinson Chandler | — | A-Award | A | Stock Options | 211,018 | 2.80 | 590.9K | 211,018 | — | ↗ |
| 2022-02-02 | Mazar Andrew Paul | — | A-Award | A | Stock Options | 88,874 | 2.80 | 248.8K | 88,874 | — | ↗ |
| 2022-02-02 | KLAUSNER ARTHUR J | — | A-Award | A | Restricted Stock Units | 11,436 | 0.00 | — | 11,436 | — | ↗ |
| 2022-02-02 | Cittadine Andrew | — | A-Award | A | Restricted Stock Units | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2022-02-02 | Brown Michael J | — | A-Award | A | Stock Options | 15,128 | 2.80 | 42.4K | 15,128 | — | ↗ |
| 2022-02-02 | Anderson Raymond | — | A-Award | A | Restricted Stock Units | 11,436 | 0.00 | — | 11,436 | — | ↗ |
| 2022-01-01 | Tsuchimoto Kim R | — | M-Exempt | A | Common Stock | 1,231 | 0.00 | — | 5,420 | — | ↗ |
| 2022-01-01 | Robinson Chandler | — | F-InKind | D | Common Stock | 2,327 | 3.21 | 7.5K | 33,733 | — | ↗ |
| 2022-01-01 | RIOUX PATRICE | — | A-Award | A | Stock Options | 10,000 | 3.21 | 32.1K | 10,000 | — | ↗ |
| 2022-01-01 | Mazar Andrew Paul | — | M-Exempt | A | Common Stock | 1,937 | 0.00 | — | 21,661 | — | ↗ |
| 2021-12-31 | Tsuchimoto Kim R | — | F-InKind | D | Common Stock | 501 | 3.21 | 1.6K | 4,189 | — | ↗ |
| 2021-12-31 | STARR CHRISTOPHER M | — | M-Exempt | D | Restricted Stock Units | 751 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Robinson Chandler | — | F-InKind | D | Common Stock | 1,364 | 3.21 | 4.4K | 29,336 | — | ↗ |
| 2021-12-31 | Mazar Andrew Paul | — | M-Exempt | D | Restricted Stock Units | 1,606 | 0.00 | — | 19,273 | — | ↗ |
| 2021-12-31 | KLAUSNER ARTHUR J | — | M-Exempt | D | Restricted Stock Units | 751 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Brown Michael J | — | M-Exempt | D | Restricted Stock Units | 751 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Anderson Raymond | — | M-Exempt | A | Common Stock | 751 | 0.00 | — | 5,294 | — | ↗ |
| 2021-09-30 | Tsuchimoto Kim R | — | F-InKind | D | Common Stock | 423 | 4.87 | 2.1K | 3,469 | — | ↗ |
| 2021-09-30 | STARR CHRISTOPHER M | — | M-Exempt | D | Restricted Stock Units | 751 | 0.00 | — | 751 | — | ↗ |
| 2021-09-30 | Robinson Chandler | — | F-InKind | D | Common Stock | 1,155 | 4.87 | 5.6K | 26,759 | — | ↗ |
| 2021-09-30 | Mazar Andrew Paul | — | F-InKind | D | Common Stock | 471 | 4.87 | 2.3K | 18,674 | — | ↗ |
| 2021-09-30 | KLAUSNER ARTHUR J | — | M-Exempt | A | Common Stock | 751 | 0.00 | — | 8,543 | — | ↗ |
| 2021-09-30 | Brown Michael J | — | M-Exempt | A | Common Stock | 751 | 0.00 | — | 213,543 | — | ↗ |
| 2021-09-30 | Anderson Raymond | — | M-Exempt | A | Common Stock | 751 | 0.00 | — | 4,543 | — | ↗ |
| 2021-07-12 | Filho Jose Octavio Pinto Costa | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-30 | Tsuchimoto Kim R | — | M-Exempt | A | Common Stock | 2,442 | 0.00 | — | 3,494 | — | ↗ |
| 2021-06-30 | STARR CHRISTOPHER M | — | M-Exempt | D | Restricted Stock Units | 752 | 0.00 | — | 1,502 | — | ↗ |
| 2021-06-30 | Robinson Chandler | — | F-InKind | D | Common Stock | 2,310 | 5.89 | 13.6K | 23,973 | — | ↗ |
| 2021-06-30 | Mazar Andrew Paul | — | F-InKind | D | Common Stock | 942 | 5.89 | 5.5K | 17,539 | — | ↗ |
| 2021-06-30 | KLAUSNER ARTHUR J | — | M-Exempt | A | Common Stock | 752 | 0.00 | — | 7,792 | — | ↗ |
| 2021-06-30 | Cittadine Andrew | — | A-Award | A | Stock Options | 30,000 | 5.89 | 176.7K | 30,000 | — | ↗ |
| 2021-06-30 | Brown Michael J | — | M-Exempt | D | Restricted Stock Units | 752 | 0.00 | — | 1,502 | — | ↗ |
| 2021-06-30 | Anderson Raymond | — | M-Exempt | D | Restricted Stock Units | 752 | 0.00 | — | 1,502 | — | ↗ |
| 2021-06-01 | Cittadine Andrew | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-31 | STARR CHRISTOPHER M | — | M-Exempt | D | Restricted Stock Units | 751 | 0.00 | — | 2,254 | — | ↗ |
| 2021-03-31 | KLAUSNER ARTHUR J | — | M-Exempt | D | Restricted Stock Units | 751 | 0.00 | — | 2,254 | — | ↗ |
| 2021-03-31 | Brown Michael J | — | M-Exempt | D | Restricted Stock Units | 751 | 0.00 | — | 2,254 | — | ↗ |
| 2021-03-31 | Anderson Raymond | — | M-Exempt | D | Restricted Stock Units | 751 | 0.00 | — | 2,254 | — | ↗ |
| 2021-02-11 | Tactic Pharma LLC | — | S-Sale | D | Common stock | 42,467 | 13.30 | 564.8K | 249,200 | — | ↗ |
| 2021-01-26 | Tsuchimoto Kim R | — | A-Award | A | Stock Options | 27,427 | 6.81 | 186.8K | 27,427 | — | ↗ |
| 2021-01-26 | STARR CHRISTOPHER M | — | A-Award | A | Stock Options | 4,443 | 6.81 | 30.3K | 4,443 | — | ↗ |
| 2021-01-26 | Robinson Chandler | — | A-Award | A | Stock Options | 70,000 | 6.81 | 476.7K | 70,000 | — | ↗ |
| 2021-01-26 | Mazar Andrew Paul | — | A-Award | A | Restricted Stock Units | 25,697 | 0.00 | — | 31,508 | — | ↗ |
| 2021-01-26 | KLAUSNER ARTHUR J | — | A-Award | A | Restricted Stock Units | 3,005 | 0.00 | — | 3,005 | — | ↗ |
| 2021-01-26 | Brown Michael J | — | A-Award | A | Restricted Stock Units | 3,005 | 0.00 | — | 3,005 | — | ↗ |
| 2021-01-26 | Anderson Raymond | — | A-Award | A | Restricted Stock Units | 3,005 | 0.00 | — | 3,005 | — | ↗ |
| 2021-01-01 | Tsuchimoto Kim R | — | M-Exempt | D | Restricted Stock Unit | 1,231 | 0.00 | — | 3,692 | — | ↗ |
| 2021-01-01 | Robinson Chandler | — | F-InKind | D | Common Stock | 2,327 | 6.12 | 14.2K | 18,400 | — | ↗ |
| 2021-01-01 | RIOUX PATRICE | — | A-Award | A | Stock options | 10,000 | 6.12 | 61.2K | 10,000 | — | ↗ |
| 2021-01-01 | Mazar Andrew Paul | — | M-Exempt | D | Restricted Stock Units | 1,937 | 0.00 | — | 5,811 | — | ↗ |
| 2020-12-31 | STARR CHRISTOPHER M | — | M-Exempt | D | Restricted Stock Units | 322 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | KLAUSNER ARTHUR J | — | M-Exempt | D | Restricted Stock Units | 322 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | Brown Michael J | — | M-Exempt | D | Restricted Stock Units | 322 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | Anderson Raymond | — | M-Exempt | A | Common Stock | 322 | 0.00 | — | 2,289 | — | ↗ |
| 2020-09-30 | STARR CHRISTOPHER M | — | M-Exempt | D | Restricted Stock Units | 322 | 0.00 | — | 322 | — | ↗ |
| 2020-09-30 | KLAUSNER ARTHUR J | — | M-Exempt | A | Common Stock | 322 | 0.00 | — | 5,967 | — | ↗ |
| 2020-09-30 | Brown Michael J | — | M-Exempt | D | Restricted Stock Units | 322 | 0.00 | — | 322 | — | ↗ |
| 2020-09-30 | Anderson Raymond | — | M-Exempt | A | Common Stock | 322 | 0.00 | — | 1,967 | — | ↗ |
| 2020-06-30 | STARR CHRISTOPHER M | — | M-Exempt | D | Restricted Stock Units | 323 | 0.00 | — | 644 | — | ↗ |
| 2020-06-30 | KLAUSNER ARTHUR J | — | M-Exempt | D | Restricted Stock Units | 323 | 0.00 | — | 644 | — | ↗ |
| 2020-06-30 | Brown Michael J | — | M-Exempt | D | Restricted Stock Units | 323 | 0.00 | — | 644 | — | ↗ |
| 2020-06-30 | Anderson Raymond | — | M-Exempt | A | Common Stock | 323 | 0.00 | — | 1,645 | — | ↗ |
Executive team
Top executives
Shares Outstanding
6.69M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Chandler D. Robinson, MD Chief Executive Officer and Director | 700.0K | 550.0K | 6.26M | 2.70M | 420.0K | — | 10.64M | 84.30% | ↗ |
| 2 | 2025 | Andrew Cittadine Chief Operating Officer | 440.0K | 325.0K | 2.34M | 1.38M | 220.0K | — | 4.71M | 79.07% | ↗ |
| 3 | 2025 | Quan Vu Chief Financial Officer, Secretary, and Treasurer | 305.0K | 100.0K | 746.2K | 795.1K | 137.3K | 17.8K | 2.10M | 73.35% | ↗ |
| 4 | 2024 | Chandler D. Robinson, MD Chief Executive Officer and Director | 603.2K | 300.0K | — | — | 241.3K | — | 1.14M | 0.00% | ↗ |
| 5 | 2024 | Andrew Cittadine Chief Operating Officer | 384.8K | 50.0K | — | 12.3K | 107.7K | — | 554.8K | 2.21% | ↗ |
| 6 | 2024 | Karthik Radhakrishnan Former Chief Financial Officer, Secretary, and Treasurer | 192.4K | — | — | 73.9K | — | 53.9K | 320.2K | 23.08% | ↗ |
| 7 | 2023 | Chandler D. Robinson, MD Chief Executive Officer and Director | 580.0K | — | 534.1K | 534.1K | 130.5K | — | 1.78M | 60.05% | ↗ |
| 8 | 2023 | Andrew Cittadine Chief Operating Officer | 360.0K | — | 247.2K | 247.2K | 56.7K | — | 911.2K | 54.27% | ↗ |
| 9 | 2023 | Kim R. Tsuchimoto Former Chief Financial Officer, Secretary, and Treasurer and Director | 300.0K | — | 247.2K | 247.2K | 54.0K | — | 848.4K | 58.28% | ↗ |
| 10 | 2022 | Chandler D. Robinson, MD Chief Executive Officer and Director | 550.0K | — | 446.7K | 446.7K | 158.1K | — | 1.60M | 55.78% | ↗ |
| 11 | 2022 | Andrew Cittadine Chief Operating Officer | 325.0K | — | 182.0K | 179.9K | 65.4K | — | 752.3K | 48.11% | ↗ |
| 12 | 2022 | Kim R. Tsuchimoto Chief Financial Officer, Secretary, Treasurer and Director | 285.0K | — | 172.3K | 172.3K | 65.6K | — | 695.1K | 49.57% | ↗ |
| 13 | 2022 | Kim R. Tsuchimoto Former Chief Financial Officer, Secretary, and Treasurer and Director | 285.0K | — | 172.3K | 172.3K | 65.6K | — | 695.1K | 49.57% | ↗ |
| 14 | 2021 | Chandler D. Robinson, MD Chief Executive Officer and Director | 524.6K | — | 429.4K | 339.5K | 135.0K | — | 1.43M | 53.83% | ↗ |
| 15 | 2021 | Chandler D. Robinson, MD, Chief Executive Officer and Director | 524.6K | — | 429.4K | 339.5K | 135.0K | — | 1.43M | 53.83% | ↗ |
| 16 | 2021 | Andrew P. Mazar, Ph.D., Former Executive Vice President of Research & Development, Chief Scientific Officer and Director | 455.5K | — | 175.0K | 175.0K | 93.8K | — | 899.3K | 38.92% | ↗ |
| 17 | 2021 | Andrew Cittadine Chief Operating Officer | 162.3K | — | — | 415.4K | 27.5K | — | 605.2K | 68.64% | ↗ |
| 18 | 2021 | Kim R. Tsuchimoto, Chief Financial Officer | 272.1K | — | 133.0K | 133.0K | 55.7K | — | 593.9K | 44.80% | ↗ |
| 19 | 2021 | Kim R. Tsuchimoto Chief Financial Officer, Secretary, Treasurer and Director | 272.1K | — | 133.0K | 133.0K | 55.7K | — | 593.9K | 44.80% | ↗ |
| 20 | 2020 | Chandler D. Robinson, MD, Chief Executive Officer and Director | 504.5K | — | 347.8K | 637.9K | 98.4K | — | 1.59M | 62.05% | ↗ |
| 21 | 2020 | Andrew P. Mazar, Ph.D., Executive Vice President of Research & Development, Chief Scientific Officer and Director | 438.0K | — | 100.2K | 293.4K | 41.0K | — | 872.6K | 45.10% | ↗ |
| 22 | 2020 | Andrew P. Mazar, Ph.D., Former Executive Vice President of Research & Development, Chief Scientific Officer and Director | 438.0K | — | 100.2K | 293.4K | 41.0K | — | 872.6K | 45.10% | ↗ |
| 23 | 2020 | Kim R. Tsuchimoto, Chief Financial Officer | 218.0K | 14.2K | 63.7K | 186.4K | 40.3K | — | 523.3K | 47.78% | ↗ |
| 24 | 2019 | Chandler D. Robinson, M.D., Chief Executive Officer and Director | 386.3K | 100.0K | — | — | — | 55.0K | 541.3K | 0.00% | ↗ |
| 25 | 2019 | Chandler D. Robinson, MD, Chief Executive Officer and Director | 386.3K | 62.5K | — | — | 37.5K | 55.0K | 541.3K | 0.00% | ↗ |
| 26 | 2019 | Andrew P. Mazar, Ph.D., Executive Vice President of Research & Development, Chief Scientific Officer and Director | 360.5K | 21.7K | — | — | 28.3K | 55.0K | 465.5K | 0.00% | ↗ |
| 27 | 2019 | Kim R. Tsuchimoto, Chief Financial Officer | 141.6K | 8.9K | — | — | 11.1K | 21.6K | 183.2K | 0.00% | ↗ |
| 28 | 2018 | Chandler D. Robinson, M.D., Chief Executive Officer and Director | 375.0K | 7.5K | — | 640.9K | — | 55.0K | 1.08M | 59.43% | ↗ |
| 29 | 2018 | Andrew P. Mazar, Ph.D., Executive Vice President of Research & Development, Chief Scientific Officer and Director | 350.0K | 5.6K | — | 591.6K | — | 55.0K | 1.00M | 59.03% | ↗ |
| 30 | 2018 | Kim R. Tsuchimoto, Chief Financial Officer | 126.0K | 2.2K | — | 181.0K | — | 18.0K | 327.2K | 55.33% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chandler D. Robinson | Co-Founder, Chief Executive Officer, President & Director | 2M | — |
| Andrew J. Cittadine | Chief Operating Officer | 985.0K | male |
| Quan Anh Vu | CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer | 623.5K | male |
| Christopher Starr | Co-Founder & Independent Executive Chairman of the Board | 200.0K | — |
| Patrice Rioux | Acting Chief Medical Officer | — | — |
| Susan Rodriguez | Chief Commercial & Strategy Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MNPR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
